CK2 Protein (Casein Kinase 2)

CK2 Protein (Casein Kinase 2)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">CK2 Protein (Casein Kinase 2)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CK2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>CK2 (Casein Kinase 2)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=CK2" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">10 edges</a></td>
</tr>
</table>

Overview

CK2 (Casein Kinase 2), also known as Protein Kinase CK2, is a constitutively active serine/threonine protein kinase that represents one of the most versatile and ubiquitous protein kinases in eukaryotic cells. Unlike many protein kinases that require activation by second messengers or phosphorylation, CK2 is constitutively active and phosphorylates over 300 known substrates involved in diverse cellular processes including transcription, translation, cell cycle progression, cell survival, and signal transduction[@ck2_structure].

CK2 Protein (Casein Kinase 2)

<table class="infobox infobox-protein">
<tr>
<th class="infobox-header" colspan="2">CK2 Protein (Casein Kinase 2)</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>CK2</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>CK2 (Casein Kinase 2)</td>
</tr>
<tr>
<td class="label">Type</td>
<td>Protein</td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprot/?query=CK2" target="_blank">Search UniProt</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">10 edges</a></td>
</tr>
</table>

Overview

CK2 (Casein Kinase 2), also known as Protein Kinase CK2, is a constitutively active serine/threonine protein kinase that represents one of the most versatile and ubiquitous protein kinases in eukaryotic cells. Unlike many protein kinases that require activation by second messengers or phosphorylation, CK2 is constitutively active and phosphorylates over 300 known substrates involved in diverse cellular processes including transcription, translation, cell cycle progression, cell survival, and signal transduction[@ck2_structure].

CK2 exists as a tetrameric holoenzyme composed of two catalytic subunits (α or α') and two regulatory β subunits. The regulatory β subunit enhances substrate specificity, modulates activity, and targets the enzyme to specific cellular compartments. CK2 is unique among protein kinases for its preference for clusters of acidic residues surrounding the phosphorylation site (S/T-X-X-E/D/pS/pT), and for its ability to utilize both ATP and GTP as phosphoryl donors[@casein_kinase_history].

The dysregulation of CK2 has been implicated in multiple diseases, including Alzheimer's disease (where it phosphorylates tau protein promoting aggregation), several cancers, and inflammatory conditions. Its central role in cell survival and proliferation makes CK2 an attractive therapeutic target, with clinical trials of CK2 inhibitors ongoing in oncology.

Protein Structure and Biochemistry

Quaternary Structure

CK2 has a distinctive tetrameric structure:

• Catalytic subunits (α/α'): ~44 kDa each, Ser/Thr protein kinase
• Regulatory subunit (β): ~38 kDa, forms dimer

• Tetramer: α₂β₂ assembly
• β dimer forms core of structure
• Catalytic subunits position on opposite sides
• Creates unique quaternary arrangement

Catalytic Subunit Structure

The CK2 catalytic subunit has a typical protein kinase fold with distinctive features[@ck2_activesite]:

• N-lobe: Contains β-strands and glycine-rich loop
• C-lobe: α-helical, substrate binding
• Active site: Deep cleft, unique substrate recognition
• ATP-binding: Uses both ATP and GTP

Regulatory Subunit

The β subunit serves multiple functions:

• Substrate targeting: Increases specificity
• Activity modulation: Can activate or inhibit
• Assembly: Dimerization core
• Localization: Targets to compartments

Substrate Recognition

CK2 has unique substrate preferences[@ck2_substrates]:

Consensus motif: S/T-X-X-D/E/pS/pT

• Serine or Threonine at position 0
• Two any residues (+1, +2)
• Acidic residue at +3 (Glu, Asp) or phosphorylated S/T

• Over 300 identified substrates
• Nuclear proteins prevalent
• Signaling molecules
• Cytoskeletal proteins

Normal Physiological Functions

Transcription Regulation

CK2 phosphorylates numerous transcription factors[@ck2_transcription]:

Nuclear receptors:

• Estrogen receptor
• Glucocorticoid receptor
• Vitamin D receptor

• c-Myc
• p53
• NF-κB

Translation

CK2 regulates translation machinery:

• eIF2B: Translation initiation
• Ribosomal proteins: Direct phosphorylation
• Translation factors: Activity modulation

Cell Cycle

CK2 is essential for cell cycle progression[@cell_cycle]:

• G1/S transition: Required
• S phase: DNA replication
• G2/M: Mitotic entry
• Centrosome function: Essential

Signal Transduction

CK2 participates in multiple signaling pathways[@ck2_signaltransduction]:

• Wnt/β-catenine[@ck2_wnt]: Modulates pathway
• PI3K/Akt[@pi3k_akt]: Cross-talk
• NF-κB[@nf_kappa_b]: Activation
• mTOR[@mtor_ck2]: Regulation

Cell Survival

CK2 promotes cell survival through multiple mechanisms[@ck2_apoptosis]:

• p53 phosphorylation[@p53_ck2]: Inactivation of pro-apoptotic function
• Akt cross-talk: Pro-survival signaling
• NF-κB activation: Anti-apoptotic gene expression

Role in Alzheimer's Disease

Tau Phosphorylation

CK2 phosphorylatestau protein at multiple AD-relevant sites[@ck2_tau]:

Target sites:

• Thr-181
• Ser-199
• Ser-235
• Thr-377

• Promotes aggregation
• Reduces microtubule binding
• Contributes to NFT formation

Amyloid Processing

CK2 affects APP processing[@ck2_app]:

• Phosphorylates APP
• Modifies amyloidogenic cleavage
• May increase Aβ production

Neuronal Dysfunction

CK2 alterations in AD neurons:

• Altered activity patterns
• Cell cycle re-entry
• Abnormal phosphorylation

Therapeutic Implications

CK2 as therapeutic target in AD[@ck2_ad]:

• Inhibitors may reduce tau pathology
• Need brain-penetrant compounds
• Timing considerations

Role in Parkinson's Disease

CK2 in PD

CK2 shows alterations in PD brains[@pd_ck2]:

• Activity changes in substantia nigra
• May affect dopaminergic neurons
• Intersects with α-synuclein pathology

Therapeutic Targeting

• CK2 inhibitors under investigation
• Neuroprotective potential

Role in Amyotrophic Lateral Sclerosis

CK2 may play roles in ALS[@aml_ck2]:

• Motor neuron vulnerability
• Altered phosphorylation patterns

Role in Cancer

CK2 is frequently upregulated in cancer[@ck2_cancer]:

• Oncogenic signaling
• Cell survival
• Therapeutic target

• CX-4945 in clinical trials[@ck2_inhibitors]
• Other compounds in development

Mitochondrial Function

CK2 localizes to mitochondria[@ck2_mitochondria]:

• Phosphorylates mitochondrial proteins
• Affects dynamics
• Alters function in disease

Autophagy

CK2 participates in autophagy regulation[@autophagy_ck2]:

• Modulates autophagic flux
• Intersects with mTOR
• Therapeutic modulation

Therapeutic Strategies

Inhibitors

Clinical development:

• CX-4945: Clinical trials
• DRB: Research compound
• TBB: Experimental
• Emodin: Natural product

• Broad kinase inhibition
• Need for selective agents

Activators

Neuroprotective approaches:

• Enhance CK2 activity
• Cell survival promotion

Research Tools

Detection

• Activity assays
• Antibody detection
• Phospho-specific antibodies

Manipulation

• siRNA/shRNA
• CRISPR
• Chemical inhibitors

Summary

CK2 (Casein Kinase 2) is a constitutively active serine/threonine protein kinase with diverse functions in transcription, translation, cell cycle, and cell survival. Its phosphorylation of tau protein at aggregation-promoting sites makes it relevant to Alzheimer's disease pathogenesis. CK2 also intersects with multiple signaling pathways (Wnt, PI3K/Akt, NF-κB, mTOR) and promotes cell survival. The enzyme is frequently upregulated in cancer, and CK2 inhibitors are in clinical development. In neurodegenerative diseases, CK2 dysregulation contributes to pathological protein phosphorylation and neuronal dysfunction. While direct CK2 inhibitors have been challenging to develop due to selectivity issues, they represent a potential therapeutic approach.

See Also

• [CSNK2A1 gene](/genes/csnpk2a1)
• [CSNK2A2 gene](/genes/csnpk2a2)
• [Tau protein (MAPT)](/proteins/tau-protein)
• [Protein kinase signaling](/mechanisms/protein-kinase-signaling)
• [Alzheimer's disease mechanisms](/mechanisms/alzheimers-pathogenesis)
• [Parkinson's disease](/diseases/parkinsons-disease)
• [Tau pathology](/mechanisms/tau-pathology)

External Links

• [UniProt: P68400 (CSNK2A1 Human)](https://www.uniprot.org/uniprot/P68400)
• [UniProt: P19784 (CSNK2B Human)](https://www.uniprot.org/uniprot/P19784)
• [NCBI Gene: 1457 (CSNK2A1)](https://www.ncbi.nlm.nih.gov/gene/1457)
• [RCSB PDB: 1JWH (CK2)](https://www.rcsb.org/structure/1JWH)
• [PhosphoSitePlus: CK2 substrates](https://www.phosphosite.org/home.action)

References